154 related articles for article (PubMed ID: 32780957)
21. Exosomal double-stranded DNA as a biomarker for the diagnosis and preoperative assessment of pheochromocytoma and paraganglioma.
Wang L; Li Y; Guan X; Zhao J; Shen L; Liu J
Mol Cancer; 2018 Aug; 17(1):128. PubMed ID: 30139385
[TBL] [Abstract][Full Text] [Related]
22. Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.
Fishbein L
Hematol Oncol Clin North Am; 2016 Feb; 30(1):135-50. PubMed ID: 26614373
[TBL] [Abstract][Full Text] [Related]
23. Multimodality Radionuclide Imaging in a Patient With Hereditary Paraganglioma-Pheochromocytoma Syndrome.
Yim SY; Moncayo VM; Pasquel FJ; Halkar RK
Clin Nucl Med; 2017 Dec; 42(12):964-965. PubMed ID: 28902732
[TBL] [Abstract][Full Text] [Related]
24. Supportive Management of Patients with Advanced Pheochromocytomas and Paragangliomas Receiving PRRT.
Tsang ES; Funk G; Leung J; Kalish G; Kennecke HF
Curr Oncol; 2021 Jul; 28(4):2823-2829. PubMed ID: 34436013
[TBL] [Abstract][Full Text] [Related]
25. Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and Paraganglioma.
Liu P; Li M; Guan X; Yu A; Xiao Q; Wang C; Hu Y; Zhu F; Yin H; Yi X; Liu L
J Kidney Cancer VHL; 2018; 5(4):14-22. PubMed ID: 30613466
[TBL] [Abstract][Full Text] [Related]
26. The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas.
Oudijk L; Papathomas T; de Krijger R; Korpershoek E; Gimenez-Roqueplo AP; Favier J; Canu L; Mannelli M; Rapa I; Currás-Freixes M; Robledo M; Smid M; Papotti M; Volante M
Neuroendocrinology; 2017; 105(4):384-393. PubMed ID: 28122379
[TBL] [Abstract][Full Text] [Related]
27. ATRX driver mutation in a composite malignant pheochromocytoma.
Comino-Méndez I; Tejera ÁM; Currás-Freixes M; Remacha L; Gonzalvo P; Tonda R; Letón R; Blasco MA; Robledo M; Cascón A
Cancer Genet; 2016 Jun; 209(6):272-7. PubMed ID: 27209355
[TBL] [Abstract][Full Text] [Related]
28. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.
Burnichon N; Cascón A; Schiavi F; Morales NP; Comino-Méndez I; Abermil N; Inglada-Pérez L; de Cubas AA; Amar L; Barontini M; de Quirós SB; Bertherat J; Bignon YJ; Blok MJ; Bobisse S; Borrego S; Castellano M; Chanson P; Chiara MD; Corssmit EP; Giacchè M; de Krijger RR; Ercolino T; Girerd X; Gómez-García EB; Gómez-Graña A; Guilhem I; Hes FJ; Honrado E; Korpershoek E; Lenders JW; Letón R; Mensenkamp AR; Merlo A; Mori L; Murat A; Pierre P; Plouin PF; Prodanov T; Quesada-Charneco M; Qin N; Rapizzi E; Raymond V; Reisch N; Roncador G; Ruiz-Ferrer M; Schillo F; Stegmann AP; Suarez C; Taschin E; Timmers HJ; Tops CM; Urioste M; Beuschlein F; Pacak K; Mannelli M; Dahia PL; Opocher G; Eisenhofer G; Gimenez-Roqueplo AP; Robledo M
Clin Cancer Res; 2012 May; 18(10):2828-37. PubMed ID: 22452945
[TBL] [Abstract][Full Text] [Related]
29. Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
Fishbein L
Curr Cardiol Rep; 2019 Jul; 21(9):104. PubMed ID: 31367972
[TBL] [Abstract][Full Text] [Related]
30. The MITF, p.E318K Variant, as a Risk Factor for Pheochromocytoma and Paraganglioma.
Castro-Vega LJ; Kiando SR; Burnichon N; Buffet A; Amar L; Simian C; Berdelou A; Galan P; Schlumberger M; Bouatia-Naji N; Favier J; Bressac-de Paillerets B; Gimenez-Roqueplo AP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4764-4768. PubMed ID: 27680874
[TBL] [Abstract][Full Text] [Related]
31. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS
Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomas.
Fernandez MC; Martin A; Venara M; Calcagno Mde L; Sansó G; Quintana S; Chemes HE; Barontini M; Pennisi PA
Clin Endocrinol (Oxf); 2013 Nov; 79(5):623-30. PubMed ID: 23506534
[TBL] [Abstract][Full Text] [Related]
33. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.
Comino-Méndez I; de Cubas AA; Bernal C; Álvarez-Escolá C; Sánchez-Malo C; Ramírez-Tortosa CL; Pedrinaci S; Rapizzi E; Ercolino T; Bernini G; Bacca A; Letón R; Pita G; Alonso MR; Leandro-García LJ; Gómez-Graña A; Inglada-Pérez L; Mancikova V; Rodríguez-Antona C; Mannelli M; Robledo M; Cascón A
Hum Mol Genet; 2013 Jun; 22(11):2169-76. PubMed ID: 23418310
[TBL] [Abstract][Full Text] [Related]
34. H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.
Oudijk L; de Krijger RR; Rapa I; Beuschlein F; de Cubas AA; Dei Tos AP; Dinjens WN; Korpershoek E; Mancikova V; Mannelli M; Papotti M; Vatrano S; Robledo M; Volante M
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1376-80. PubMed ID: 24684458
[TBL] [Abstract][Full Text] [Related]
35. PD-L1 expression and association with malignant behavior in pheochromocytomas/paragangliomas.
Guo D; Zhao X; Wang A; Xie Q; Xu X; Sun J
Hum Pathol; 2019 Apr; 86():155-162. PubMed ID: 30594747
[TBL] [Abstract][Full Text] [Related]
36. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
Stenman A; Zedenius J; Juhlin CC
Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
[TBL] [Abstract][Full Text] [Related]
37. The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma.
Kimura N; Shiga K; Kaneko K; Sugisawa C; Katabami T; Naruse M
Endocr Pathol; 2020 Jun; 31(2):95-100. PubMed ID: 32303954
[TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
[TBL] [Abstract][Full Text] [Related]
39. Somatic RET mutation in a patient with pigmented adrenal pheochromocytoma.
Maison N; Korpershoek E; Eisenhofer G; Robledo M; de Krijger R; Beuschlein F
Endocrinol Diabetes Metab Case Rep; 2016; 2016():150117. PubMed ID: 26843961
[TBL] [Abstract][Full Text] [Related]
40. Pheochromocytomas and paragangliomas in humans and dogs.
Galac S; Korpershoek E
Vet Comp Oncol; 2017 Dec; 15(4):1158-1170. PubMed ID: 28120550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
